• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
ebola
JOIN
Posted on March 13, 2016September 14, 2023

Pathways to preterm birth

Need for developing case definitions and guidelines for data collection, analysis, and presentation for pathways to preterm birth...
Read More
Posted on March 13, 2016September 14, 2023

Systemic Lupus Erythematosus

Need for developing case definitions and guidelines for data collection, analysis, and presentation for systemic lupus erythematos...
Read More
Posted on February 13, 2016September 14, 2023

Hypertensive disorders of pregnancy

Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders...
Read More
Posted on March 13, 2013September 14, 2023

Narcolepsy as an Adverse Event Following Immunization

The need for developing a case definition for narcolepsy as an adverse event following immunization (AEFI): 1.1.1. General Intr...
Read More
Posted on September 10, 2012September 14, 2023

Viscerotropic disease

Need for developing case definitions and guidelines for viscerotropic disease as an adverse event following immunization: Visce...
Read More
Posted on March 13, 2012September 14, 2023

Immunization site pain

Need for developing a case definition and guidelines for immunization site pain as an adverse event following immunization [AEFI]:...
Read More
Posted on October 10, 2011September 14, 2023

Diarrhea

Need for developing a case definition and guidelines for diarrhea as an adverse event following immunization [AEFI]: Diarrhea,...
Read More
Posted on April 13, 2008September 14, 2023

A local reaction at or near injection site

The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the devel...
Read More
Posted on December 10, 2007September 14, 2023

Rash including mucosal involvement

Rash was the third most common adverse events reported by the U.S. Vaccine Adverse Event Reporting System (VAERS) during 1991–20...
Read More
Posted on October 13, 2007September 14, 2023

Progressive vaccinia as an adverse event following exposure to vaccinia virus

Need for developing case definitions and guidelines for adverse events following exposure to vaccinia virus: Following a declar...
Read More
Previous page 1 … 4 5 6 7 8 Next page

Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026
  • Acute Multi-Organ DysfunctionJune 2, 2026
  • WHO Resource References Brighton Collaboration StandardsMay 11, 2026

Most Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026

Posts

  • Brighton Collaboration News — Summer 2026
  • Fetal Vaccinia
  • Acute Intraocular Inflammation
  • Acute Multi-Organ Dysfunction
  • WHO Resource References Brighton Collaboration Standards
  • Request for Review: Acute Multi-Organ Dysfunction (aMOD) Brighton Case Definition
  • In Memory of Dr. William Foege
  • Brighton Collaboration News — December 2025
  • Request for Review: Acute Intraocular Inflammation Draft Brighton Case Definition
  • Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever
Download.pdf
Download.txt

Contact us for help?

Contact with us through our representative or submit a business inquiry online.

Contact Us

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy